Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis

BACKGROUND: Currently available antifibrotic treatments may slow down disease progression in idiopathic pulmonary fibrosis (IPF), but are associated with potentially significant side effects and are costly. Mycophenolate mofetil (MMF) is well known for its potent immunosuppressive properties and pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Nambiar, Anoop M., Anzueto, Antonio R., Peters, Jay I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404863/
https://www.ncbi.nlm.nih.gov/pubmed/28441449
http://dx.doi.org/10.1371/journal.pone.0176312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404863/
https://www.ncbi.nlm.nih.gov/pubmed/28441449
http://dx.doi.org/10.1371/journal.pone.0176312

Ejemplares similares